NOVO.B.DK

247.85

-3.71%↓

GMAB.DK

1,731.5

-2.37%↓

HLUNB.DK

43.08

-0.6%↓

ZEAL.DK

301.4

-4.35%↓

AMBUB.DK

69.5

-0.43%↓

NOVO.B.DK

247.85

-3.71%↓

GMAB.DK

1,731.5

-2.37%↓

HLUNB.DK

43.08

-0.6%↓

ZEAL.DK

301.4

-4.35%↓

AMBUB.DK

69.5

-0.43%↓

NOVO.B.DK

247.85

-3.71%↓

GMAB.DK

1,731.5

-2.37%↓

HLUNB.DK

43.08

-0.6%↓

ZEAL.DK

301.4

-4.35%↓

AMBUB.DK

69.5

-0.43%↓

NOVO.B.DK

247.85

-3.71%↓

GMAB.DK

1,731.5

-2.37%↓

HLUNB.DK

43.08

-0.6%↓

ZEAL.DK

301.4

-4.35%↓

AMBUB.DK

69.5

-0.43%↓

NOVO.B.DK

247.85

-3.71%↓

GMAB.DK

1,731.5

-2.37%↓

HLUNB.DK

43.08

-0.6%↓

ZEAL.DK

301.4

-4.35%↓

AMBUB.DK

69.5

-0.43%↓

Search

Coloplast A-S (Class B)

Fermé

429.2 -1.27

Résumé

Variation du prix de l'action

24h

Actuel

Min

429.2

Max

438.3

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.148

63.808

BPA

6.32

Rendement du dividende

5.41

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.41%

2.38%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-22B

96B

Ouverture précédente

430.47

Clôture précédente

429.2

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

20 avr. 2026, 23:49 UTC

Principaux Événements d'Actualité

New Zealand 1Q Inflation Higher Than Expected

20 avr. 2026, 23:10 UTC

Actions en Tendance

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 avr. 2026, 22:53 UTC

Principaux Mouvements du Marché

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 avr. 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 avr. 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 avr. 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20 avr. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 avr. 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20 avr. 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 avr. 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 avr. 2026, 22:31 UTC

Acquisitions, Fusions, Rachats

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 avr. 2026, 22:26 UTC

Acquisitions, Fusions, Rachats

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Aims for Acquisition to Be Completed by End-2026

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 avr. 2026, 22:25 UTC

Acquisitions, Fusions, Rachats

West African Resources Says Acquisition Would Be for A$175 Million

20 avr. 2026, 22:24 UTC

Acquisitions, Fusions, Rachats

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 avr. 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 avr. 2026, 22:01 UTC

Acquisitions, Fusions, Rachats

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 avr. 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 avr. 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 avr. 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 avr. 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20 avr. 2026, 21:13 UTC

Résultats

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 avr. 2026, 21:10 UTC

Résultats

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 avr. 2026, 21:09 UTC

Résultats

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 avr. 2026, 21:08 UTC

Résultats

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 avr. 2026, 21:07 UTC

Résultats

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 avr. 2026, 21:05 UTC

Résultats

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 avr. 2026, 21:05 UTC

Résultats

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat